- Session 1a: COVID-19 vaccine modelling
- Session 1b: Optimizing COVID-19 vaccine costing
- Session 2: Measles Case Fatality Ratio (CFR) estimation
- Session 3: Overview of Vaccine Impact Modelling Consortium (VIMC)
- Session 4: Meta-analysis of Economic Evaluations
- Session 5: Full Public Health Value of Vaccines (FPHVV) - Influenza Vaccine
- Session 6: IA 2030 Costing
- Ad hoc session (February 2021): IA 2030 vaccine impact estimates
Immunization and vaccines related implementation research advisory committee (IVIR-AC) - March 2021
Related
Background materials
IVIR-AC Pink Book March 2021
(download file and open in PDF viewer for access to full content)
(download file and open in PDF viewer for access to full content)